These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14142337)

  • 41. Letter: Permeability of blood-cerebrospinal fluid barrier during foetal and perinatal life.
    Saunders NR; Dziegielewska KM; Malinowska DH; Reynolds ML; Reynolds ML; Mollgard K; Reynolds JM
    Nature; 1976 Jul; 262(5564):156. PubMed ID: 945471
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on the permeability of the blood-brain, blood-cerebro-spinal fluid and cerebro-spinal fluid-brain barriers for proteins under physiological conditions and of the blood-brain barrier for albumins in cerebral edema].
    Wiśniewski H
    Neuropatol Pol; 1965; 3(1):1-33. PubMed ID: 5846241
    [No Abstract]   [Full Text] [Related]  

  • 43. Spectrophotometric studies in the cerebrospinal fluid in the newborn, especially for the demonstration of blood.
    Kunnas M; Leppänen VV
    Ann Paediatr Fenn; 1967; 13(3):89-95. PubMed ID: 5591502
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the problem of permeability of the barrier between the blood and the cerebrospinal fluid in acute cerebral hypoxia].
    Bartko D; Danisová J; Wagnerová M
    Bratisl Lek Listy; 1968 Jun; 49(6):651-8. PubMed ID: 5668847
    [No Abstract]   [Full Text] [Related]  

  • 45. [Absorption spectra of nucleic acids and related compounds in the spectral region 120--280 nm].
    Kiseleva MN; Zarochentseva EP; Dodonova NIa
    Biofizika; 1975; 20(4):561-5. PubMed ID: 1081409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colourimetric and spectroscopic discrimination between nucleotides and nucleosides using para-sulfonato-calix[4]arene capped silver nanoparticles.
    Tauran Y; Grosso M; Brioude A; Kassab R; Coleman AW
    Chem Commun (Camb); 2011 Sep; 47(36):10013-5. PubMed ID: 21833429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The dynamics of cerebrospinal fluid circulation (author's transl)].
    Sato O
    No Shinkei Geka; 1976 Mar; 4(3):211-7. PubMed ID: 775355
    [No Abstract]   [Full Text] [Related]  

  • 48. THE BLOOD-CEREBROSPINAL FLUID BARRIER IN CHRONIC SCHIZOPHRENIA AND AFTER TRIFLUOPERAZINE (STELAZINE) TREATMENT.
    GUERRANT J; BECKER RA; ANDERSON WW; AIRD RB
    J Nerv Ment Dis; 1964 Sep; 139():222-31. PubMed ID: 14212174
    [No Abstract]   [Full Text] [Related]  

  • 49. CLINICAL ASPECTS OF THE BLOOD-BRAIN BARRIER.
    BARLOW CF
    Annu Rev Med; 1964; 15():187-202. PubMed ID: 14133843
    [No Abstract]   [Full Text] [Related]  

  • 50. [Molecular diffusion/cerebrospinal fluid flow theory].
    Dorta-Contreras AJ; Reiber H
    Rev Neurol; 2004 Sep 16-30; 39(6):564-9. PubMed ID: 15467996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
    Tumani H; Huss A; Bachhuber F
    Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of the unbound brain concentration of P-glycoprotein substrates or nonsubstrates by a serial cerebrospinal fluid sampling technique in rats.
    Mariappan TT; Kurawattimath V; Gautam SS; Kulkarni CP; Kallem R; Taskar KS; Marathe PH; Mandlekar S
    Mol Pharm; 2014 Feb; 11(2):477-85. PubMed ID: 24380373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Abnormal cerebrospinal fluid proteins in schizophrenia].
    Sizaret P; Degiovanni A; Martin JC
    Ann Med Psychol (Paris); 1972 Nov; 2(4):507-13. PubMed ID: 4120433
    [No Abstract]   [Full Text] [Related]  

  • 54. Magnesium exchange between blood and cerebrospinal fluid.
    Oppelt WW; MacIntyre I; Rall DP
    Am J Physiol; 1963 Nov; 205(5):959-62. PubMed ID: 5877425
    [No Abstract]   [Full Text] [Related]  

  • 55. [Glycogen of the choroid plexus and age factor in chemical composition of the cerebrospinal fluid].
    PURIN VR
    Vopr Med Khim; 1958; 4(5):345-50. PubMed ID: 13604018
    [No Abstract]   [Full Text] [Related]  

  • 56. [DYNAMICS OF THE BROMINE CONTENT OF THE BLOOD IN PATIENTS WITH SPACE-OCCUPYING FORMATIONS IN THE BRAIN AND WITH SYMPTOMS OF CEREBROSPINAL FLUID OCCLUSION].
    KNIRIK GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1485-8. PubMed ID: 14328172
    [No Abstract]   [Full Text] [Related]  

  • 57. [Relations between the level of ascorbic acid in the cerebrospinal fluid and the blood].
    GOUNELLE H; VALLETTE A
    C R Seances Soc Biol Fil; 1945 Apr; 139():404-6. PubMed ID: 21012694
    [No Abstract]   [Full Text] [Related]  

  • 58. [OLIGOPHRENIA, ATAXIA, BILATERAL CATARACT (MARINESCO-SJOEGREN SYNDROME) ASSOCIATED WITH CONGENITAL TOXOPLASMOSIS].
    ZLATOVEROV AI; IARTSEVA LV; KRSILNIKOVA NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():1478-81. PubMed ID: 14183977
    [No Abstract]   [Full Text] [Related]  

  • 59. [Correlation between levels of blood glucose and cerebrospinal fluid glucose and proteins in diabetes mellitus].
    Musić M
    Med Arh; 2004; 58(1):31-3. PubMed ID: 15017901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A review on cerebrospinal fluid cytomorphology and proteins].
    Ito N
    No To Shinkei; 1982 Jul; 34(7):631-42. PubMed ID: 6182895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.